BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 107635)

  • 1. Effect of an adenosine deaminase inhibitor on survival of mouse pancreatic islet allografts.
    Lum CT; Sutherland DE; Eckhardt J; Matas AJ; Najarian JS
    Transplantation; 1979 May; 27(5):355-7. PubMed ID: 107635
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of mouse and rat pancreatic islet cell allografts by adenosine deaminase inhibitors and adenine arabinoside.
    Lum CT; Sutherland DE; Payne WD; Gorecki P; Matas AJ; Najarian JS
    J Surg Res; 1980 Jan; 28(1):44-8. PubMed ID: 6767140
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of early loss of transplanted islets in the liver of mice by adenosine.
    Nitta T; Itoh T; Matsuoka N; Mera T; Kojima D; Nakano M; Yamashita Y; Yasunami Y
    Transplantation; 2009 Jul; 88(1):49-56. PubMed ID: 19584680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of murine islet allograft survival by pretreatment of islets with 2-chloroadenosine.
    Takeda Y; Satomi S; Miura S; Koja S; Morimoto K; Okazaki H; Taguchi Y; Mori S
    Transplant Proc; 1993 Feb; 25(1 Pt 2):971-2. PubMed ID: 8442285
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cholera toxin on pancreatic islet transplantation in mice.
    Takeda Y; Satomi S; Miura S; Koja S; Morimoto K; Okamoto M; Oguma S; Taguchi Y; Mori S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):873-4. PubMed ID: 1990709
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.
    Glazer RI
    Cancer Chemother Pharmacol; 1980; 4(4):227-35. PubMed ID: 7002342
    [No Abstract]   [Full Text] [Related]  

  • 7. Acceptance of intrahepatic islet allografts without immunosuppression in the limited strain combination of mice from C57BL/6 to BALB/c.
    Nagai T; Yasunami Y; Ikehara Y; Kodama S; Maki T; Ikeda S
    Transplant Proc; 1998 Mar; 30(2):418. PubMed ID: 9532107
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine deaminase inhibition for immunosuppression.
    Chassin MM; Chirigos MA; Johns DG; Adamson RH
    N Engl J Med; 1977 May; 296(21):1232. PubMed ID: 854065
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of the bioactive enantiomer of erythro-3-(adenin-9-yl)-2-nonanol (EHNA), a semi-tight binding inhibitor of adenosine deaminase.
    Baker DC; Hanvey JC; Hawkins LD; Murphy J
    Biochem Pharmacol; 1981 May; 30(10):1159-61. PubMed ID: 7259798
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition.
    Bessodes M; Bastian G; Abushanab E; Panzica RP; Berman SF; Marcaccio EJ; Chen SF; Stoeckler JD; Parks RE
    Biochem Pharmacol; 1982 Mar; 31(5):879-82. PubMed ID: 7082355
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose rapamycin unmasks the protective potential of targeting intragraft NF-κB for islet transplants.
    Zammit NW; Tan BM; Walters SN; Liuwantara D; Villanueva JE; Malle EK; Grey ST
    Cell Transplant; 2013; 22(12):2355-66. PubMed ID: 23127588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
    Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model.
    Fu F; Hu S; Li S; DeLeo J; Hoover J; Wang S; Lake P; Shi V
    Transplant Proc; 2001; 33(1-2):672-3. PubMed ID: 11267010
    [No Abstract]   [Full Text] [Related]  

  • 14. Pravastatin and low-dose cyclosporine treatment prevent islet allograft rejection in mice.
    Arita S; Kasraie A; Une S; Ohtsuka S; Atiya A; Shevlin L; Mullen Y
    Transplant Proc; 1998 Mar; 30(2):522. PubMed ID: 9532158
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 16. Facilitation of specific tolerance induction in adult mice by RS-61443.
    Hao L; Calcinaro F; Gill RG; Eugui EM; Allison AC; Lafferty KJ
    Transplantation; 1992 Mar; 53(3):590-5. PubMed ID: 1549852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of concanavalin A on mouse islet cell transplantation.
    Zhu XY; He J; Yang PA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):954-6. PubMed ID: 3152647
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition for immunosuppression.
    Lum CT; Sutherland DE; Najarian JS
    N Engl J Med; 1977 Apr; 296(14):819. PubMed ID: 320485
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-toxicity immunosuppression by specific inhibition of adenosine deaminase (ADA): prolongation of mouse skin grafts with erythro-9-(2-hydroxy-3-nonyl) adenine hydrochloride (EHNA).
    Lum CT; Sutherland DE; Foker JE; Najarian JS
    Surg Forum; 1977; 28():320-2. PubMed ID: 364724
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.